Malin-backed Poseida Therapeutics files for IPO on Nasdaq exchange
Poseida is one of four priority assets in which the life sciences company has stakes
Malin-backed biotech company raises $142m
Poseida Therapeutics uses genome engineering to develop cancer treatments
Dublin-listed Malin secures €70m debt facility from EIB
Company to use facility to increase investments in European life sciences sector
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices